I agree, a PE ratio cannot summarise whether a business is "cheap" or "expensive" and many other metrics must be used. Should AD8 be able to grow its EBITDA (or revenues, or EPS, - whatever you want to choose) by your the previous year 80% level, than sure, today's price might be a bargain. But 80% CAGR is massive. NVIDIA has done something like 40% CAGR the last 5 years. So AD8 would have to shoot the lights out consistently for at least 5 years. Can it? Possibly? I won't say it can't. But the current earnings (and poor guidance for FY25) wouldn't fill me with confidence.
- Forums
- ASX - By Stock
- AD8
- Ann: FY24 Preliminary Unaudited Results & FY25 Outlook
Ann: FY24 Preliminary Unaudited Results & FY25 Outlook, page-53
Featured News
Add AD8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.86 |
Change
-0.110(1.23%) |
Mkt cap ! $743.4M |
Open | High | Low | Value | Volume |
$8.90 | $9.02 | $8.80 | $942.9K | 106.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 930 | $8.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.87 | 406 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 930 | 8.850 |
8 | 1373 | 8.840 |
9 | 1829 | 8.830 |
6 | 922 | 8.820 |
5 | 1498 | 8.810 |
Price($) | Vol. | No. |
---|---|---|
8.870 | 389 | 9 |
8.880 | 5958 | 8 |
8.890 | 1527 | 7 |
8.900 | 514 | 4 |
8.910 | 2192 | 6 |
Last trade - 14.24pm 18/11/2024 (20 minute delay) ? |
Featured News
AD8 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online